Anti-TIM3 induced global changes in the immune response within the glioma, as reflected by increases in the phagocytic MG, cDC2, CD8 cytotoxic, inflammatory MG, CD4 Tcm, and monocyte populations. Here, CD4 is linked to central nervous system cancer.